Not yet a member?Join now!|Lost password
08/17/2012 | Press release
distributed by noodls on 08/19/2012 07:20
In a paper published online August 15 by the journal, Blood, a team from the University of North Carolina's Lineberger Comprehensive Cancer Center, shows in the laboratory that B cells from patients with chronic Graft vs. Host Disease are much more active than cells from patients without the disease. The team also outlines the cell signaling pathways that contribute to this increased activity - identifying a promising target for developing new therapies for the diseases.
Click here to read full press release.
###
Among the research institutions NCI funds across the United
States, it currently designates 67 as Cancer Centers. Largely
based in research universities, these facilities are home to
many of the NCI-supported scientists who conduct a wide range
of intense, laboratory research into cancer's origins and
development. The Cancer Centers Program also focuses on
trans-disciplinary research, including population science and
clinical research. The centers' research results are often at
the forefront of studies in the cancer field.